Completed PHASE2 INTERVENTIONAL 2-arm NCT00680940

A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer (NSCLC)

Open Label, Randomized Multicentric Phase II Clinical Trial of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel and Cisplatin in Advanced Non Small Cell Lung Cancer.

Sponsor: Cadila Pharnmaceuticals

Conditions Non Small Cell Lung Cancer

Interventions Mycobacterium w. Paclitaxel & Cisplatin

Updated 6 times since 2017 Last updated: Aug 4, 2012 Started: Jun 30, 2008 Primary completion: Dec 31, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Non Small Cell Lung Cancer and is currently completed. Cadila Pharnmaceuticals leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cadila Pharnmaceuticals

Data source: Cadila Pharnmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Asarwa, India , Bikaner, India , Calicut, India , Coimbatore, India , Gobindnagar, India , Indore, India , Jalandhar, India , Kolkata, India , New Alipore, India , Red Hills, India and 2 more locations